Related Experiment Videos
Renal Medullary Carcinoma; A Rare Entity
Selahattin Çalışkan1, Ali Murat Gökçe2, Gülistan Gümrükçü3
1Department of Urology, Çorum Training and Research Hospital, Hitit University, Çorum, Turkey.
Iranian Journal of Medical Sciences
|April 1, 2017
Summary
Renal medullary carcinoma (RMC) is a rare, aggressive kidney cancer with a poor prognosis. Research suggests it may arise from chronic hypoxia in the renal papillae, possibly linked to sickled erythrocytes.
Area of Science:
- Nephrology
- Oncology
- Pathology
Background:
- Renal medullary carcinoma (RMC) is an aggressive kidney neoplasm with a high propensity for metastasis.
- The exact origin and pathogenesis of RMC remain largely unknown.
- Histologically, RMC is characterized by poorly differentiated eosinophilic cells within a fibro-inflammatory stroma.
Observation:
- Radiographical and pathological findings suggest RMC may originate from calyceal epithelium near renal papillae.
- Chronic ischemic damage to renal papillae epithelium, potentially caused by sickled erythrocytes, is a hypothesized factor.
- Vascular Endothelial Growth Factor (VEGF) and Hypoxia-Inducible Factor 1-alpha (HIF-1α) positivity supports a role for chronic hypoxia.
Findings:
- The study describes an adult Turkish patient presenting with hematuria, diagnosed with RMC.
- The case highlights the aggressive nature and metastatic potential of RMC.
- The pathogenesis may involve chronic hypoxia, genetic, or environmental factors, despite the rarity of RMC in the context of common hemoglobinopathies.
Implications:
- Understanding the molecular and genetic factors of RMC is crucial for developing effective prevention and treatment strategies.
- Further research into the link between hypoxia, sickled erythrocytes, and RMC pathogenesis is warranted.
- This case contributes to the limited literature on RMC, emphasizing the need for increased awareness and research into this rare malignancy.